Aphria selling down shares at 40 cents (27% discount to listed price), page-71

I think that there is an awful lot of negativity at the moment due to the drop in share price, however I think it is important to remember the following:

Firstly this company has phenomenal growth month on month.

Secondly it has 30% market share largely due to its Concierge platform reducing barrier to entry for both customers and medical practitioners.The true effect of the Concierge and only in its infancy and patient numbers will ramp up. They have been first to market and a building there brand.

Thirdly what value do you put on Althea's potential UK business and the fact that they have been included Twenty21 trial of 20000 patients. Althea have said that they believe that the UK patient numbers will be higher than the Australian number in Q1 2020. If they have forecast 4000 Aus patients by the end of the 2019 and if the UK numbers are higher than the Aus numbers in Q1 then with over 8000 patients conservatively then this company looks very different to where it is at now.

Fourthly the acquisition is staged so that targets are hit, and there is a trigger of $12.5 million EBITA which must be achieved for the acquisition to be finalised. $30 million for a business that is going to yield $12.5 million I think is a great investment. As an example take a look at other shares like GEM who are acquiring businesses at 4.5 to 6 times EBITA. The EBITA multiple for Peak is less than 2.5 times at the time of purchase but obviously is affected by what the sahre price is now and in the future.

I see a period of uncertainty for the next month but then I think it will be onward and upward on a long hold for mine. I certainly can't understand negative posts from people holding the share "Sidage". Nothing personal but it doesn't make sense.